The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan

Podobne knjige/članki

• Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and SAHA in lymphoma cell lines
  od: Valdez, Benigno C., et al.
  Izdano: (2011)
• Synergistic cytotoxicity of sorafenib with busulfan and nucleoside analogs in human FLT3-ITD-positive acute myeloid leukemia cells
  od: Song, Guiyun, et al.
  Izdano: (2014)
• Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines
  od: Valdez, Benigno C., et al.
  Izdano: (2012)
• 5-Aza-2′-deoxycytidine Sensitizes Busulfan-resistant Myeloid Leukemia Cells By Regulating Expression of Genes Involved in Cell Cycle Checkpoint and Apoptosis
  od: Valdez, Benigno C., et al.
  Izdano: (2009)
• Altered gene expression in busulfan-resistant human myeloid leukemia
  od: Valdez, Benigno C., et al.
  Izdano: (2008)